Evidence map›Paper›PMID 36299251›Full record

ArticleMolecular genetics and metabolism reports2022

MPS VII - Extending the classical phenotype.

A Oldham, N J Oxborrow, P Woolfson, P Jenkins, C Gadepalli, J Ashworth, A Saxena, M Rothera, C J Hendriksz, G Tol and 1 more

Abstract readCase Reports
In one paragraph

Article in Molecular genetics and metabolism reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

A OldhamMark Holland Metabolic Unit, Salford Royal NHS Foundation Trust, United Kingdom.
N J OxborrowSalford Royal NHS Foundation Trust, United Kingdom.
P WoolfsonCardiology Department, Salford Royal NHS Foundation Trust, United Kingdom.
P JenkinsNorth West Congenital Heart Disease Partnership, Mark Holland Metabolic Unit, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, United Kingdom.
C GadepalliDepartment of Ear, Nose and Throat, Salford Royal NHS Foundation Trust, United Kingdom.
J AshworthManchester Royal Eye Hospital, Manchester Foundation NHS Trust, United Kingdom.
A SaxenaNeurosurgery, Salford Royal NHS Foundation Trust, United Kingdom.
M RotheraRoyal Manchester Children's Hospital, United Kingdom.
C J HendrikszUniversity of Pretoria, Mark Holland Metabolic Unit, Salford Royal NHS Foundation Truist, Stott Lane, Salford, M6 8HD, United Kingdom.
G TolSalford Royal NHS Foundation Trust, United Kingdom.
A JovanovicMark Holland Metabolic Unit, Salford Royal NHS Foundation Trust, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucopolysaccharidosis VII (or Sly syndrome) is an autosomal recessive disorder characterised by a deficiency in the enzyme Beta-glucuronidase (

Indexed as

Case reportGUSBMucopolysaccharidosis VIISly syndrome

Identifiers

PMID36299251
PMCPMC9589197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.